Isolation of 3,3'-neotrehalosadiamine (BMY-28251) from a butirosin-producing organism.
Isolation of 3,3'-neotrehalosadiamine (BMY-28251) from a butirosin-producing organism.
复制标题
从产生布替罗辛的生物体中分离 3,3-新海藻糖二胺 (BMY-28251)。
DOI:
10.7164/antibiotics.39.1346
复制
发表时间:
1986
期刊:
影响因子:
--
通讯作者:
H. Kawaguchi
中科院分区:
文献类型:
--
作者:
K. Numata;F. Satoh;M. Hatori;T. Miyaki;H. Kawaguchi
Sir: The aminoglycoside hypersensitive mutant of Klebsiella pneumoniae (Kp-126) was isolated and used for a specific detection of new aminoglycoside-type antibiotics'). From the fermentation broth of a butirosin-producing strain, 3,3'neotrehalosadiamine (BMY-28251) was detected as a minor component specifically active against strain Kp-126. This communication describes the isolation and identification of BMY-28251 from Bacillus circulans YQW-B62'. The medium FR8 containing soluble starch 2 %, glucose 0.2 %, soybean meal 3 %, MgSO, • 7H2O 0.3 % and CaCO3 1 % was used for the production of BMY-28251. A well-grown agar slant of strain YQW-B6 was inoculated to 100 ml of the heart infusion broth (Difco) in 500-ml Erlenmeyer flask and incubated at 32°C for 24 hours on a rotary shaker (180 rpm) to obtain seed culture. Two ml of the culture was transferred into 100 ml of medium FR8 in 500-m1 flask which was shaken at 28°C for 4 days. The broth filtrate (2 liters) was adsorbed onto a column of Amberlite IRC-50 (70% NH4+ form). The column was washed with H2O and then eluted with I N NH4OH. Active eluates were combined and concentrated in vacuo to afford hygroscopic solid (2.8 g) as a total active fraction. A part of the solid (150 mg) was dissolved in a small amount of H,O and applied to a column (1.0 cm x 37 cm) of Amberlite CG-50 (NH,+ form). The column was developed stepwise at a flow rate of 0.25 nil/minute with H2O (fraction Nos. 1 10), 0.15 N NH,OH (fraction Nos. 11 30) and 0.5 N NH,OH (fraction Nos. 31 80). The antibiotic activity in each 5 ml of the elute was monitored by the paper disc-agar diffusion method using Kp-126 and Bacillus subtilis PCI 219 (Bs-1) as test organisms. As shown in Fig. 1, peak I, designated as component X, was highly active against Kp-126 but only weakly against Bs-1. The other two peaks showed comparable activity against Kp-126 and Bs-1. Peak III